Motley Fool Wealth Management, LLC Ultragenyx Pharmaceutical Inc. Transaction History

Motley Fool Wealth Management, LLC

$1.54 Billion
Q2 2025

A detailed history of Motley Fool Wealth Management, LLC transactions in Ultragenyx Pharmaceutical Inc. stock. As of the latest transaction made, Motley Fool Wealth Management, LLC holds 275,082 shares of RARE stock, worth $9.46 Million. This represents 0.65% of its overall portfolio holdings.

Number of Shares

275,082

Previous 149,596 83.88%

Holding current value

$9.46 Million

Previous $5.42 Million 84.66%

% of portfolio

0.65%

Previous 0.34%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 01, 2025	BUY	$31.06 - $39.3 $3.9 Million - $4.93 Million	125,486 Added 83.88%	275,082 $10 Million
Q1 2025 May 12, 2025	SELL	$36.21 - $45.78 $153,494 - $194,061	-4,239 Reduced 2.76%	149,596 $5.42 Million
Q4 2024 Feb 11, 2025	SELL	$42.07 - $57.72 $596,552 - $818,469	-14,180 Reduced 8.44%	153,835 $6.47 Million
Q3 2024 Nov 14, 2024	SELL	$40.21 - $59.36 $95,900 - $141,573	-2,385 Reduced 1.4%	168,015 $9.33 Million
Q2 2024 Aug 08, 2024	BUY	$37.42 - $51.61 $236,644 - $326,381	6,324 Added 3.85%	170,400 $7 Million
Q1 2024 May 08, 2024	SELL	$43.02 - $53.69 $6,840 - $8,536	-159 Reduced 0.1%	164,076 $7.66 Million
Q4 2023 Feb 02, 2024	SELL	$31.73 - $49.19 $127,681 - $197,940	-4,024 Reduced 2.39%	164,235 $7.85 Million
Q3 2023 Nov 13, 2023	BUY	$34.92 - $46.66 $2.03 Million - $2.71 Million	58,139 Added 52.8%	168,259 $6 Million
Q2 2023 Aug 09, 2023	BUY	$37.35 - $52.15 $149 - $208	4 Added 0.0%	110,120 $5.08 Million
Q1 2023 May 10, 2023	BUY	$36.99 - $48.71 $2.04 Million - $2.69 Million	55,232 Added 100.63%	110,116 $4.42 Million
Q4 2022 Feb 09, 2023	SELL	$33.72 - $46.33 $38,238 - $52,538	-1,134 Reduced 2.02%	54,884 $2.54 Million
Q3 2022 Nov 14, 2022	BUY	$39.96 - $66.14 $2,317 - $3,836	58 Added 0.1%	56,018 $2.32 Million
Q2 2022 Aug 11, 2022	SELL	$45.8 - $85.4 $11,679 - $21,777	-255 Reduced 0.45%	55,960 $3.34 Million
Q1 2022 May 04, 2022	BUY	$62.2 - $84.4 $4,416 - $5,992	71 Added 0.13%	56,215 $4.08 Million
Q4 2021 Feb 10, 2022	SELL	$73.71 - $87.86 $143,587 - $171,151	-1,948 Reduced 3.35%	56,144 $4.72 Million
Q3 2021 Nov 12, 2021	SELL	$77.92 - $102.4 $91,867 - $120,729	-1,179 Reduced 1.99%	58,092 $5.24 Million
Q2 2021 Aug 13, 2021	SELL	$92.19 - $115.71 $40,655 - $51,028	-441 Reduced 0.74%	59,271 $5.65 Million
Q1 2021 May 11, 2021	BUY	$106.9 - $167.73 $6.38 Million - $10 Million	59,712 New	59,712 $6.8 Million

Others Institutions Holding RARE

# of Institutions

362

Shares Held

88.2M

Call Options Held

3.64M

Put Options Held

2.24M

View Full List

About Ultragenyx Pharmaceutical Inc.

Ticker RARE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,036,896
Market Cap $2.41B
Description
Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast...

More about RARE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Motley Fool Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Motley Fool Wealth Management, LLC with notifications on news.

Account

Motley Fool Wealth Management, LLC Ultragenyx Pharmaceutical Inc. Transaction History